The association of dietary pyridoxine deficiency and convulsions was first noted in animal experiments by Chick, El Sadr and Worden (1940) . An analogous situation in humans was recognized when Snyderman, Carretero and Holt (1950) described the onset of seizures in a mentally retarded child whose diet lacked this vitamin. Shortly afterwards, an outbreak of convulsions in young infants in the United States was shown to be due to the low pyridoxine content in their diet (Coursin, 1954; Molony, 1954; Bessey, Adam, Bussey and Hansen, 1954; Adam, Bessey, Bussey and Hansen, 1954; May, 1954 ). An association of a different category was first recorded when Hunt, Stokes, McCrory and Stroud (1954) described the case of an infant who began to suffer from seizures a few hours after birth. Pyridoxine in high doses abolished the attacks, and the term 'pyridoxine dependency' was used to describe this situation in which convulsions are of early onset and dietary deficiency cannot be invoked. Only three other reports have been encountered (Bessey, Adam and Hansen, 1957; Marie, Hennequet, Lyon, Debris and Le Balle, 1959; Scriver, 1960) describing infants whose attacks similarly responded to pyridoxine therapy.
The case reported here seems to fulfil the criteria for its acceptance as a further instance of convulsions associated with a state of pyridoxine dependency.
Case Report A female infant born of Iraqi Jewish parents, was admitted six hours after birth, because of severe generalized convulsions. The father was healthy; the mother was known to suffer from aortic valvular disease and nephrolithiasis. There had been 10 pregnancies, the fourth, sixth and eighth terminating in spontaneous abortion in the first and second trimesters. Two infants, one male, one female, born at term following normal pregnancies (the seventh and ninth) died between the ages of 1 and 3 months, after repeated convulsions which first appeared shortly after birth.
The present pregnancy and delivery were normal, the infant breathed spontaneously and weighed 2,800 g. Generalized convulsions had been present almost 21 continuously for two hours in spite of parenteral barbiturates and chloral hydrate. She was cyanotic except for brief periods of respite, the slightest touch or noise provoking a short tonic spasm with cyanosis and apnoea. No 9bnormalities were detected on physical examination.
Investigations. Lumbar puncture revealed a clear cerebrospinal fluid, containing 3 cells; protein 140 mg./ 100 ml., sugar 67 mg./100 ml. Subdural needling was dry. Sabin-Feldman test, Wassermann and Nelson tests, in the infant and her parents, were negative. Blood chemistry revealed calcium 10 mg./100 ml., phosphorus 6 mg./100 ml., alkaline phosphatase 10 Bodansky units, fasting sugar 82 mg./100 ml., urea 24 mg./100 ml., sodium 140 mEq/litre; chloride 99 mEq/litre; C02-combining power 52%; total protein 5 5 g./100 ml., albumin 3-31 g./100 ml., electrophoresis of blood proteins normal. Liver tests normal. Transaminase (glutamic-oxalacetic) 55 units. Haemoglobin 18 g./100 ml., erythrocytes 5,400,000, leucocytes and differential count normal. Chromatography of amino acids in urine normal. Ferric chloride test negative. Radiographs of skull revealed no calcifications or other abnormalities.
Electroencephalogram was abnormal and showed periodic groups of medium to high voltage generalized beta and theta waves with occasional spikes. These bursts lasted from two to five seconds, and alternated in an irregular fashion with periods of very fast waves of extremely low voltage, almost amounting to electrical silence (Fig. 1) (Fig. 2) . The daily dosage was gradually then maintained on an oral daily dose of 7 5 mg. of reduced to 2-5 mg. with no untoward effect. On the 58th day, therapy was interrupted in order to perform a tryptophane-loading test. There was no xanthurenic acid in the urine after a tryptophane load of 0 54 g./kg. body weight. Severe convulsions recurred 48 hours later, and the electroencephalogram was once again abnormal, with periods of high voltage activity made up of mixed slow and fast frequencies and numerous sharp waves. These episodes lasted from seconds to a minute or two and again were interspersed with passages of sudden complete cessation of electrical activity. Convulsions were almost constant except in the electrically silent periods (Fig. 3) . Parenteral barbiturates were ineffective and cessation of convulsions followed within 10 minutes of injection of 2-5 mg. pyridoxine. The electroencephalogram was normal the next day (Fig. 4) . The infant is now on a maintenance dose of 2 mg. pyridoxine. During a trial to reduce the daily dose to I mg., she was restless and irritable.
Discussion
The exact mechanism responsible for the appearance of convulsions in states of pyridoxine deficiency and dependency is not known. Pyridoxal coenzyme, one of the forms in which vitamin B6 occurs in foods and body fluids, is required for the intermediary metabolism of amino acids (Snell, 1953; 1958) . Increased urinary excretion of xanthurenic acid after tryptophane loading is one of the meta- bolic defects noted in pyridoxine deficiency (Snyderman et al., 1950; Bessey et al., 1957; Rabe and Plonko, 1956) or when a pyridoxine antagonist is administered (Mueller and Vilter, 1950; Biehl and Vilter, 1954; Price, Brown and Larson, 1957 (Sokoloff, Lasson, McKhann, Tower and Albers, 1959) , was found to be reduced in brains of rats given toxopyrimidine, an antagonist of pyridoxine (Rindi and Ferrari, 1959) . In the states of deficiency, small doses of pyridoxine, almost equivalent to the normal daily requirement, are needed to suppress the convulsions, whereas in the states of dependency, much higher doses are required (Coursin, 1955) . Absorptive defect being excluded, and excessive renal loss of vitamin Be being unlikely to affect the availability of pyridoxal coenzyme in the states of dependency, an abnormality of the apoenzyme system of the brain, with increased demand for the coenzyme was postulated by Scriver (1960) . The early onset of convulsions and the continuous high dosage of pyridoxine required to abolish them in our patient preclude pyridoxine deficiency. Hunt et al. (1954) suggested that the state of 'dependency' could be related to a high prenatal maternal intake of the vitamin, but no vitamin supplements had been administered during this pregnancy. For this reason a genetic enzymatic abnormality of the infant's brain metabolism seems likely. This may well have been the case in the two siblings who died of convulsions. Summary A case is presented in which severe generalized seizures, unresponsive to routine anticonvulsant therapy, began a few hours after birth. No cause for the seizures was discovered, but treatment with pyridoxine resulted in their cessation. The convulsions recurred 36 to 48 hours after withdrawal of therapy. This is believed to be the fifth reported publication of pyridoxine-dependent convulsions.
Two untreated siblings died with the same symptoms. The cause of the disorder is believed to be genetic enzymatic abnormality of the brain.
